Topic

Nucala (mepolizumab)

A collection of 32 issues

How to Get Nucala (Mepolizumab) Covered by Cigna in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Nucala Covered by Cigna in Georgia Cigna requires prior authorization for Nucala (mepolizumab) with specific eosinophil count thresholds and step therapy documentation. For severe eosinophilic asthma, you'll need ≥300 cells/μL eosinophils within 6 weeks, failure of high-dose inhaled corticosteroids plus long-acting beta-agonist, and specialist

Getting Nucala (Mepolizumab) Covered by Humana in Washington: Complete Forms, Appeals & Support Guide

Answer Box: Fast Track to Nucala Coverage Nucala (mepolizumab) requires prior authorization for Humana Medicare Advantage plans in Washington. Submit the 2024 Request for Medicare Prescription Drug Coverage Determination Form with eosinophil counts ≥150 cells/μL and evidence of optimized inhaled therapy failure. Use CoverMyMeds for fastest processing (often under

Work With Your Doctor to Get Nucala (Mepolizumab) Approved by Humana in Michigan: Complete Provider Collaboration Guide

Answer Box: Getting Nucala Covered by Humana in Michigan Humana requires prior authorization for Nucala (mepolizumab) with specific criteria: blood eosinophils ≥150 cells/μL, severe asthma despite high-dose ICS/LABA therapy, and ≥2 exacerbations requiring systemic steroids annually. Your pulmonologist or allergist must submit documentation via Humana's provider

Work With Your Doctor to Get Nucala (Mepolizumab) Approved by UnitedHealthcare in Virginia: Complete Guide

Answer Box: Getting Nucala Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Nucala (mepolizumab) through OptumRx, with approval based on severe eosinophilic asthma criteria including blood eosinophil count ≥150 cells/μL and poor asthma control despite optimized therapy. Your fastest path: (1) Schedule a visit to document current

How to Get Nucala (Mepolizumab) Covered by UnitedHealthcare in Washington: State Appeals Guide with Forms and Timelines

Answer Box: Getting Nucala Covered in Washington Washington residents have strong protections when UnitedHealthcare denies Nucala (mepolizumab) for severe eosinophilic asthma. State law requires step therapy exceptions within 72 hours if prior biologics failed or are contraindicated. After internal appeals, you can request binding external review through an Independent Review

How to Get Nucala (Mepolizumab) Covered by Cigna in Ohio: Complete Prior Authorization, Appeals, and Cost Guide

Quick Answer: Getting Nucala (Mepolizumab) Covered by Cigna in Ohio Nucala requires prior authorization from Cigna/Express Scripts for severe eosinophilic asthma, typically covered on specialty tier with 6-month initial approval. Key requirements: prescribed by specialist, blood eosinophils ≥150-300 cells/μL, failed high-dose ICS + LABA therapy ≥3 months. First step

How to Get Nucala (mepolizumab) Covered by Blue Cross Blue Shield in Ohio: Complete PA Guide with Appeals

Answer Box: Quick Path to Nucala Coverage in Ohio To get Nucala (mepolizumab) covered by Blue Cross Blue Shield in Ohio: Submit prior authorization with blood eosinophil count ≥150-300 cells/μL, documentation of severe eosinophilic asthma uncontrolled on high-dose inhaled therapy, and specialist prescription. If denied, file internal appeal within

How to Get Nucala (Mepolizumab) Covered by Cigna in New Jersey: Complete Forms, Appeals, and Contact Guide

Answer Box: Getting Cigna Coverage for Nucala in New Jersey Cigna requires prior authorization for Nucala (mepolizumab) with specific clinical criteria including blood eosinophil levels ≥300 cells/μL within 6 weeks and documented failure of high-dose inhaled corticosteroids plus LABA therapy. Submit requests via CoverMyMeds or Cigna's provider

How to Get Nucala (mepolizumab) Covered by Blue Cross Blue Shield in Washington: Complete PA Guide with Appeal Scripts

Answer Box: Getting Nucala Covered in Washington Blue Cross Blue Shield plans in Washington require prior authorization for Nucala (mepolizumab) with strict criteria: blood eosinophils ≥150 cells/µL or ≥300 cells/µL in past year, failed high-dose inhaled therapy, and specialist prescription. Most approvals come within 15 business days when

Work With Your Doctor to Get Nucala (Mepolizumab) Approved by Humana in Ohio: Complete PA Guide

Answer Box: Getting Nucala Covered by Humana in Ohio Nucala (mepolizumab) requires prior authorization from Humana, with approval based on severe eosinophilic asthma diagnosis, blood eosinophil count ≥150 cells/μL, and documented failure of high-dose inhaled therapy. Work with your allergist or pulmonologist to submit a complete PA request via